These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glucocorticoids and their actions: an introduction. Charmandari E; Kino T; Chrousos GP Ann N Y Acad Sci; 2004 Jun; 1024():1-8. PubMed ID: 15265770 [No Abstract] [Full Text] [Related]
4. [The effect of glucocorticoid on neural system development]. Hu JF; Sui N; Kuang PZ; Guan LC Sheng Li Ke Xue Jin Zhan; 1999 Jul; 30(3):214-8. PubMed ID: 12532782 [TBL] [Abstract][Full Text] [Related]
7. Seminars in medicine of the Beth Israel Deaconess Medical Center. Neuroendocrine responses to starvation and weight loss. Schwartz MW; Seeley RJ N Engl J Med; 1997 Jun; 336(25):1802-11. PubMed ID: 9187072 [No Abstract] [Full Text] [Related]
8. Reinterpretation of basal glucocorticoid feedback: implications to behavioral and metabolic disease. Laugero KD Vitam Horm; 2004; 69():1-29. PubMed ID: 15196877 [TBL] [Abstract][Full Text] [Related]
9. Hypothesis paper Brain talks with fat--evidence for a hypothalamic-pituitary-adipose axis? Schäffler A; Binart N; Schölmerich J; Büchler C Neuropeptides; 2005 Aug; 39(4):363-7. PubMed ID: 16040119 [TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Stimson RH; Walker BR Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154 [TBL] [Abstract][Full Text] [Related]
12. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease. Walker BR; Andrew R Ann N Y Acad Sci; 2006 Nov; 1083():165-84. PubMed ID: 17148739 [TBL] [Abstract][Full Text] [Related]
13. The hypothalamic-pituitary-adrenocortical system: Hormonal brain-gut interaction and gastroprotection. Filaretova L Auton Neurosci; 2006 Apr; 125(1-2):86-93. PubMed ID: 16481222 [TBL] [Abstract][Full Text] [Related]
14. Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women. Duclos M; Marquez Pereira P; Barat P; Gatta B; Roger P Obes Res; 2005 Jul; 13(7):1157-66. PubMed ID: 16076984 [TBL] [Abstract][Full Text] [Related]
15. Controversies, new risk factors and the neuroendocrine approach to fibromyalgia: can therapeutic progress be made at last? Shipton E N Z Med J; 2003 May; 116(1174):U439. PubMed ID: 12766785 [No Abstract] [Full Text] [Related]
16. Is hypothalamic-pituitary-adrenal hyperactivity important in the pathogenesis of excessive abdominal fat distribution? Streeten DH J Clin Endocrinol Metab; 1993 Aug; 77(2):339-40. PubMed ID: 8345038 [No Abstract] [Full Text] [Related]
17. From Malthus to motive: how the HPA axis engineers the phenotype, yoking needs to wants. Pecoraro N; Dallman MF; Warne JP; Ginsberg AB; Laugero KD; la Fleur SE; Houshyar H; Gomez F; Bhargava A; Akana SF Prog Neurobiol; 2006 Aug; 79(5-6):247-340. PubMed ID: 16982128 [TBL] [Abstract][Full Text] [Related]
18. Shaping the stress response: interplay of palatable food choices, glucocorticoids, insulin and abdominal obesity. Warne JP Mol Cell Endocrinol; 2009 Mar; 300(1-2):137-46. PubMed ID: 18984030 [TBL] [Abstract][Full Text] [Related]
19. Regulation of the hypothalamic-pituitary-adrenal axis. Papadimitriou A; Priftis KN Neuroimmunomodulation; 2009; 16(5):265-71. PubMed ID: 19571587 [TBL] [Abstract][Full Text] [Related]
20. Fast glucocorticoid actions on brain: back to the future. Dallman MF Front Neuroendocrinol; 2005; 26(3-4):103-8. PubMed ID: 16242180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]